Is NuScale Power Going to $120?

NuScale Power’s stock is discussed as a speculative long-term 10x candidate, but the math is challenging: a move from about $12 to $120 would imply a roughly $40 billion market cap and about $1.7 billion in annual revenue, versus just $31.5 million in 2025 revenue. The article notes NuScale has not yet deployed a single SMR, though it is gaining momentum with a Romania project and a potential 6 GW TVA partnership. Overall, the piece highlights upside potential but emphasizes the substantial execution risk and distant timeline.

Analysis

The market is implicitly valuing SMR more like a platform monopoly than a project developer, but the path to that multiple is a financing-and-execution gauntlet, not a simple “nuclear AI trade.” The biggest second-order issue is that every additional unit deployed raises the need for project finance, fuel-cycle commitments, EPC capacity, and regulatory confidence; if any one of those bottlenecks stays tight, the equity story gets pushed out by years rather than quarters. That matters because the current valuation still leaves very little room for a prolonged pre-revenue buildout.

The more interesting relative winners are not SMR itself but incumbent power producers and grid-adjacent industrials that can monetize near-term load growth without taking first-of-a-kind construction risk. CEG and GEV benefit from the market’s renewed willingness to pay up for “nuclear exposure,” yet they already have operating cash flow to absorb rate and supply-chain volatility, which should keep them in a much more durable institutional bucket. If the SMR narrative gains traction, expect capital to rotate toward the parts of the value chain that can scale fastest: turbine, transformer, switchgear, and EPC bottleneck suppliers, rather than pure-play reactor IP.

The contrarian read is that the stock could still work, but only if investors reprice it as a decade-long call option on regulatory replication rather than a near-term commercial growth story. That suggests the move is likely underowned by long-duration investors but overhyped by traders expecting reactor revenue to arrive on a normal software-like timeline. The key catalyst is not design approval; it is a first bankable project with financing closed and construction milestones that de-risk serial deployment. Until then, the equity is vulnerable to any delay, because the market is paying today for a supply chain and customer adoption curve that does not yet exist.

Key Decisions for Investors

• Avoid chasing SMR into strength; treat it as a long-dated call option only after a financed first-project close. Risk/reward is poor here because any schedule slip likely compresses multiple before operating revenue exists.
• Prefer a relative long CEG vs. short SMR pair over the next 3-6 months. CEG has real earnings power and should capture any broad nuclear rerating with far less execution risk; SMR remains headline-driven and dilution-prone.
• Add selective exposure to GEV on pullbacks as the cleaner beneficiary of nuclear buildout and grid capex. If SMR momentum pulls capital into the theme, GEV should see lower-volatility multiple support without binary project risk.
• Watch for a first project financing announcement from SMR as the real catalyst window. If financing is project-level and non-dilutive, the stock can re-rate sharply; if equity-funded, downside likely resumes on dilution concerns.
• Use options rather than common for SMR exposure: small notional long-dated calls only after a confirmed commercial milestone. This preserves upside if the rollout becomes serial, while capping loss if deployment slips by 12-24 months.